# Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China

> **NCT01647191** · NA · COMPLETED · sponsor: **Shanghai Mental Health Center** · enrollment: 240 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **BEHAVIORAL:** intervention group
- **BEHAVIORAL:** control group

## Key facts

- **NCT ID:** NCT01647191
- **Lead sponsor:** Shanghai Mental Health Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-01
- **Primary completion:** 2015-05-01
- **Final completion:** 2015-05-31
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01647191

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01647191, "Reducing Hepatitis C Virus (HCV)/Human Immunodeficient Virus (HIV) Risk Behaviors Among Injection Drug Users in China". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01647191. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*